These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16716512)

  • 1. gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain.
    Itoh N; Masuo Y; Yoshida Y; Cynshi O; Jishage K; Niki E
    Neurosci Lett; 2006 Jul; 403(1-2):136-40. PubMed ID: 16716512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY; Jang EH; Park CS; Kang JH
    Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
    Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
    Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
    Liang Y; Li S; Zou Q; Su B
    Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Tocopherol transfer protein is not required for the discrimination against γ-tocopherol in vivo but protects it from side-chain degradation in vitro.
    Grebenstein N; Schumacher M; Graeve L; Frank J
    Mol Nutr Food Res; 2014 May; 58(5):1052-60. PubMed ID: 24420818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
    Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H
    Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B; Leng A; Mura A; Hengerer B; Feldon J
    J Neurochem; 2004 May; 89(4):822-33. PubMed ID: 15140182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats.
    Jiang Q; Ames BN
    FASEB J; 2003 May; 17(8):816-22. PubMed ID: 12724340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets.
    Traber MG; Siddens LK; Leonard SW; Schock B; Gohil K; Krueger SK; Cross CE; Williams DE
    Free Radic Biol Med; 2005 Mar; 38(6):773-85. PubMed ID: 15721988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
    Abdel-Wahab MH
    J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo modulation of the Parkinsonian phenotype by Nrf2.
    Burton NC; Kensler TW; Guilarte TR
    Neurotoxicology; 2006 Dec; 27(6):1094-100. PubMed ID: 16959318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
    Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel cyclooxygenase-2 inhibitor GW637185X protects against l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Aguirre JA; Leo G; Cueto R; Andbjer B; Naylor A; Medhurst AD; Agnati LF; Fuxe K
    Neuroreport; 2008 Apr; 19(6):657-60. PubMed ID: 18382281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.